Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_assertion type Assertion NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_head.
- NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_assertion description "[Activation of the receptor tyrosine kinases (RTKs), epidermal growth factor receptor and MET, has been described in subsets of mesothelioma, suggesting that TKs might represent therapeutic targets in this highly lethal disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_provenance.
- NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_assertion evidence source_evidence_literature NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_provenance.
- NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_assertion SIO_000772 21132014 NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_provenance.
- NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_assertion wasDerivedFrom befree-20150227 NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_provenance.
- NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_assertion wasGeneratedBy ECO_0000203 NP945849.RAFTxyRJXNL1OMZxjTTLSe_Nc7qWMCXdHMKWIg0G-cdgU130_provenance.